It reduces IL-6, interleukin-17 (IL-17), IL-12 and other plasma protein levels of inflammation-related cytokines and down-regulated the levels of plasma proteins associated with the NF-kB signaling pathway in CKD patients [259]. The gene discussed is IL6; the disease is chronic kidney disease.